Fosaprepitant Accord

Fosaprepitant Accord is an antiemetic medication used to prevent nausea and vomiting caused by chemotherapy. It is administered intravenously and is manufactured by Accord Healthcare B.V.

Fosaprepitant Accord is primarily used to prevent nausea and vomiting in patients undergoing chemotherapy. It works by blocking substances in the body that can trigger these symptoms. This medication is often prescribed to patients who are receiving highly emetogenic chemotherapy treatments.

Fosaprepitant Accord may cause common side effects such as fatigue, headache, and diarrhea. Some patients may also experience changes in taste or constipation. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Fosaprepitant Accord should be used with caution in patients with a history of liver disease or severe kidney impairment. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Pregnant or breastfeeding women should consult their doctor before using this medication.

Fosaprepitant Accord may interact with other medications, including certain antifungals, antibiotics, and HIV protease inhibitors. It is also important to avoid grapefruit juice while taking this medication, as it can affect how fosaprepitant is metabolized in the body.